Intercept Pharmaceuticals completes venture financing

Intercept Pharmaceuticals Inc., New York, N.Y. Business: Hepatic, Endocrine/Metabolic Date completed: 8/9/12 Type: Venture financing Raised: $30 million Investors: OrbiMed Advisors; Genextra ...